Stock 2315 BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Equities

2315

CNE100005D27

End-of-day quote Hong Kong S.E.
Other stock markets
 23:00:00 19/06/2024 BST 		5-day change 1st Jan Change
7.5 CNY -3.85% Intraday chart for Biocytogen Pharmaceuticals (Beijing) Co., Ltd. -6.83% -37.40%
06-04 XtalPi Inc. announced that it has received CNY 337 million in funding from Shanghai Guosheng Investment Group, Biocytogen Pharmaceuticals Co., Ltd., FaaS Capital Longevity Limited and other investors CI
05-06 Biocytogen Enters into Evaluation and Potential Licensing Agreement with Biocopy for TCR-mimic Antibodies CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. Stock Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
 399M -
MODERNA, INC. Stock Moderna, Inc.
 51.07B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.78B
LONZA GROUP AG Stock Lonza Group AG
 38.61B
CELLTRION, INC. Stock Celltrion, Inc.
 27.32B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.35B
  1. Stock Market
  2. Equities
  3. 2315 Stock
  4. Charts Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  5. Sector Chart